Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6056563 | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology | 2013 | 6 Pages |
Abstract
This retrospective study suggests that END should be recommended as a preferred management strategy for stage T2 to T4 disease and that observation may be an acceptable alternative to END for stage T1 tumors if strict compliance with a cancer surveillance protocol is followed.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Zhien MD, PhD, Jian Nan MD, Chuan Zhen MD, Chuan Bin MD, PhD,